Patents Assigned to Xiamen University
  • Publication number: 20230174592
    Abstract: Disclosed are a fusion protein probe and a cell model for screening a blocking agent of coronavirus infections, a screening system comprising same, and a method of using the screening system for screening a blocking agent of coronavirus infections. The screening system and method do not involve live viruses, are simple and convenient to operate, have a high accuracy, are suitable for high throughput screening, and are of great significance for the development of coronavirus neutralizing antibodies, preventive vaccines, and small molecule drugs.
    Type: Application
    Filed: April 30, 2021
    Publication date: June 8, 2023
    Applicants: YANG SHENG TANG COMPANY, LTD., XIAMEN UNIVERSITY
    Inventors: Yali ZHANG, Shaojuan WANG, Yangtao WU, Wangheng HOU, Jianghui YE, Juan WANG, Tianying ZHANG, Tong CHENG, Quan YUAN, Ningshao XIA
  • Patent number: 11650274
    Abstract: A method for acquiring nuclear magnetic resonance (NMR) phase-sensitive two-dimensional (2D) J-resolved spectrum by suppressing strong coupling spurious peaks, comprising: 1) placing a sample, collecting a conventional one-dimensional (1D) spectrum of the sample, and measuring a time width (pw) of a 90° pulse, wherein the conventional 1D spectrum provides J coupling information and chemical shift information of the sample; and 2) introducing a pulse sequence for suppressing strong coupling, setting parameters of a chirp sweep frequency pulse, a pure shift yielded by chirp excitation (PSYCHE) module, and a J sampling module, and collecting and saving data of a spectrum.
    Type: Grant
    Filed: April 4, 2022
    Date of Patent: May 16, 2023
    Assignee: Xiamen University
    Inventors: Yuqing Huang, Zhong Chen, Cunyuan Gao, Haolin Zhan
  • Publication number: 20230105190
    Abstract: The present disclosure relates to the technical field of medicine, and in particular to a fibroblast activation protein inhibitor (FAPI) dimer compound, an FAPI dimer-based positron emission tomography (PET) imaging agent for tumor diagnosis, and a preparation method and use thereof An amphiphilic polyethylene glycol (PEG) chain and a dimerized structure of FAPI in the FAPI dimer compound with a structure shown in formula I provided by the present disclosure can improve the in vivo kinetic properties of the compound and prolong a residence time of the compound in a tumor, thereby improving the uptake and imaging effects in the tumor. The accurate tumor diagnosis can be achieved by labeling the FAPI dimer compound with a diagnostic nuclide (68Ga), which has promising application prospects in PET imaging for diagnosis and in the preparation of a therapeutic nuclide (such as 177Lu or 90Y)-labeled drug for treating a FAP-?-expressing tumor.
    Type: Application
    Filed: September 29, 2022
    Publication date: April 6, 2023
    Applicant: XIAMEN UNIVERSITY
    Inventors: Haojun CHEN, Liang ZHAO, Qin LIN, Kaili FU, Yizhen PANG, Zhide GUO, Jianyang FANG, Long SUN, Hua WU
  • Patent number: 11597809
    Abstract: A method for preparing an aerogel comprising nano attapulgite and phenolic aldehyde and a method for preparing abrasion-resistant vehicle tire. 80-100 weight distributions of rubber, 3-8 weight distributions of SiO2.nH2O, 3-6 weight distributions of an anti-aging agent, 3-4 weight distributions of a heat stabilizer, 3-5 weight distributions of a compatibilizing agent, and 3-12 weight distributions of the aerogel comprising the nano attapulgite and the phenolic aldehyde is selected as a raw material of the abrasion-resistant rubber material to prepare rubber composite material for the abrasion-resistant vehicle tire.
    Type: Grant
    Filed: February 8, 2022
    Date of Patent: March 7, 2023
    Assignee: Xiamen University
    Inventors: Lizong Dai, Xiaohui Liu, Hesheng Cao, Guorong Chen, Weiang Luo, Conghui Yuan, Birong Zeng, Yiting Xu
  • Publication number: 20230057621
    Abstract: The present invention relates to the medical field, and in particular to the use of adefovir dipivoxil and a structural analog thereof for treating pseudorabies virus. In particular, the invention relates to the use of a compound as shown in formula (I), a stereoisomer thereof, a solvate thereof, a pharmaceutically acceptable salt thereof or a solvate of the pharmaceutically acceptable salt thereof for inhibiting the pseudorabies virus, treating pseudorabies virus infections or treating diseases related to pseudorabies virus infections.
    Type: Application
    Filed: October 26, 2020
    Publication date: February 23, 2023
    Applicants: XIAMEN UNIVERSITY, YANG SHENG TANG COMPANY, LTD.
    Inventors: Yixin CHEN, Guosong WANG, Pengfei HUANG, Ruiqi CHEN, Lina LIN, Qiangyuan HAN, Ningshao XIA
  • Patent number: 11587270
    Abstract: Disclosed is a method for reconstruction of a Chemical Exchange Saturation Transfer (CEST) contrast image. The method includes: generating training samples for a deep neural network; training the deep neural network with the training samples to obtain a trained deep neural network; and reconstructing a CEST contrast image by using the trained deep neural network and PROPELLER undersampled CEST images. The method for reconstruction of a CEST contrast image can effectively shorten the experimental time of a CEST contrast imaging and can obtain a smoother and more accurate CEST contrast image. Further disclosed is a system for reconstruction of a CEST contrast image to implement the method for reconstruction.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: February 21, 2023
    Assignee: XIAMEN UNIVERSITY
    Inventors: Shuhui Cai, Chenlu Guo, Congbo Cai, Jian Wu
  • Patent number: 11551479
    Abstract: A motion behavior pattern classification method, system and device relating to the human motion recognition field. The method includes: S1, determining a candidate motion behavior pattern which includes a motion behavior pattern to be classified; S2, acquiring time series of behavior data of the candidate motion behavior pattern through a motion control sensor; S3, establishing an LSTM motion behavior pattern classification model through the time series; S4, predicting the motion behavior pattern to be classified through the LSTM motion pattern classification model, comparing the prediction result obtained using the sequence within the T time with the prediction result obtained using the sequence within the T+?t time using the iterative process to obtain the final prediction result, wherein T1?T?T2, T1>0, T2>T1, and the incremental step is set to be ?t, ?t>0. The technical solution of the present invention may improve accuracy while reducing the latency of the motion behavior pattern classification.
    Type: Grant
    Filed: October 30, 2019
    Date of Patent: January 10, 2023
    Assignee: XIAMEN UNIVERSITY
    Inventors: Shihui Guo, Juncong Lin, Minghong Liao, Chenxu Lu, Min Jiang, Xing Gao, Guilin Li, Xinyu Shi, Zeyong Hu
  • Patent number: 11543413
    Abstract: A kit for quantitatively detecting HBsAg and a method for quantitatively detecting an HBsAg content in a sample containing HBsAg. The kit comprises a first antibody specifically binding to HBsAg and a reagent composition. The reagent composition comprises tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and urea.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: January 3, 2023
    Assignees: XIAMEN INNODX BIOTECH CO., LTD, XIAMEN UNIVERSITY
    Inventors: Shunhua Wen, Liuwei Song, Zuxing Weng, Haijun Lin, Feihai Xu, Xudong Sun, Shengxiang Ge
  • Patent number: 11542240
    Abstract: Provided herein are compositions and methods for the treatment and prevention of cancer, including melanoma.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: January 3, 2023
    Assignees: TRUSTEES OF BOSTON UNIVERSITY, XIAMEN UNIVERSITY
    Inventors: Rutao Cui, Chengqian Yin, Xianming Deng, Ting Zhang
  • Patent number: 11510683
    Abstract: A fistula bandage comprising a bandage and an adjustment device for adjusting a tension of the bandage, where the adjustment device comprises: a first engagement portion connected to a first end of the bandage; and a second engagement portion connected to a second end of the bandage; wherein the second engagement portion comprises: a base having a first sliding slot and connected to the second end of the bandage; a moving member slidingly engaged with the base and connected to the first engagement portion; a driving mechanism supported on the base and driving the moving member to slide in a first direction relative to the base; and a stopping mechanism connected to the driving mechanism. The driving mechanism drives the first engagement portion to move relative to the second engagement portion, thereby achieving the purpose of adjusting the tension of the bandage.
    Type: Grant
    Filed: December 7, 2019
    Date of Patent: November 29, 2022
    Assignee: ZHONGSHAN HOSPITAL XIAMEN UNIVERSITY
    Inventors: Wei Han, Rongrong Zong, Yilin Deng, Tianjun Guan, Qiuying Han, Lan Chen
  • Patent number: 11512120
    Abstract: The present disclosure discloses an antimicrobial peptide Scyreprocin of Scylla paramamosain and a method thereof, wherein an amino acid sequence of the antimicrobial peptide Scyreprocin comprises a sequence shown in SEQ ID NO 01, and the antimicrobial peptide is expressed and purified by using genetic engineering technology. The recombinant antimicrobial peptide Scyreprocin has advantages of wide antimicrobial spectrum, good antimicrobial effect, and rapid germicidal rate, shows great application significance, and has good application in preparation of antimicrobial agents. The recombinant antimicrobial peptide Scyreprocin has no cytotoxicity to mouse hepatocytes AML12, human liver cells L02, and can be safely used for medical treatment or can be used as a feed composition.
    Type: Grant
    Filed: April 14, 2021
    Date of Patent: November 29, 2022
    Assignee: Xiamen University
    Inventors: Kejian Wang, Ying Yang, Fangyi Chen, Yanchao Chen, Huiyun Chen, Hui Peng
  • Patent number: 11505684
    Abstract: A vehicle tire rubber composite material, raw materials of the vehicle tire rubber composite material comprise the following components by weight: 30-40 weight distributions of solution-polymerized styrene-butadiene rubber, 35-55 weight distributions of rare earth butadiene rubber, 10-30 weight distributions of phenyl modified natural rubber, 5-14 weight distributions of polyurethane elastomer, 3-9 weight distributions of acetylene carbon black, 2-5 weight distributions of multifunctional abrasion-resistant flame retardant Cu@HNT@MoS2-PZE, 3-6 weight distributions of elastic fiber, 1-3 weight distributions of heat stabilizer, 2-3 weight distributions of silane coupling agent, 1-2.5 weight distributions of anti-scorching agent, 1-2.5 weight distributions of turpentine oil, and 4-6 weight distributions of accelerator.
    Type: Grant
    Filed: February 8, 2022
    Date of Patent: November 22, 2022
    Assignees: Xiamen University, Cheng Shin Tire (Xiamen) Co., Ltd.
    Inventors: Lizong Dai, Jing Hong, Hesheng Cao, Guorong Chen, Weiang Luo, Conghui Yuan, Birong Zeng, Yiting Xu
  • Patent number: 11505656
    Abstract: The invention relates to a method for embedding a load based on gel high hydrostatic pressure liquefaction. Using the phenomenon that the physical gel is liquefied under high pressure, the vacuum-packaged high-methoxyl pectin gel is treated under a pressure of 400-600 MPa for 5-30 min, mixed with the load, and then subjected to a pressure of 400-600 MPa for homogenization treatment for 5 to 30 min. After pressure relief, the liquefied gel is poured into a mold for reshaping, followed by removal of free water and coating treatment. This method combines the advantages of high hydrostatic pressure technology in modification and sterilization. It has mild embedding conditions and wide sources of raw materials to prepare the carrier, which has excellent biocompatibility and biodegradability. It can be widely used for embedding microorganisms, enzymes, proteins and small molecular substances. The loaded gel prepared by the method has high microbial safety, can effectively maintain the activity of the load.
    Type: Grant
    Filed: April 3, 2019
    Date of Patent: November 22, 2022
    Assignee: XIAMEN UNIVERSITY
    Inventors: Liming Che, Xiang Li, Ning He, Xue'e Wu, Yuanpeng Wang, Xueping Ling
  • Patent number: 11500257
    Abstract: An inorganic solid-state electrochromic module containing an inorganic transparent conductive film, including a transparent substrate and a first transparent conductive layer, a first transparent metal layer, a first transparent protective layer, an inorganic electrochromic layer, an inorganic ion conductive layer, an inorganic ion storage layer, a second transparent metal layer, a second transparent protective layer, a second transparent conductive layer, a encapsulating film and a transparent front plate successively formed on the transparent substrate.
    Type: Grant
    Filed: April 6, 2020
    Date of Patent: November 15, 2022
    Assignee: XIAMEN UNIVERSITY OF TECHNOLOGY
    Inventors: An Xie, Ling Zhang, Guang Cao, Yuechan Li, Dongya Sun, Minshu Zhang, Liang Yang, Chunyan Cao
  • Patent number: 11489205
    Abstract: The present disclosure discloses a primary lithium battery comprising a reactive solid cathode, a liquid electrolyte, a separator, and a lithium anode. The liquid electrolyte is ionic conductive and is configured to undergo a series coupling reaction after solid phase reaction of the reactive solid cathode and the lithium anode. The liquid electrolyte comprises a solvent and an electrolyte salt, and a concentration of the electrolyte salt in the liquid electrolyte is 0.1-3 mol/L. The solvent comprises a sulfite ester type compound and an organic solvent, and a concentration of the sulfite ester type compound in the organic solvent is 5 wt % to 90 wt %.
    Type: Grant
    Filed: May 15, 2020
    Date of Patent: November 1, 2022
    Assignee: XIAMEN UNIVERSITY
    Inventors: Yong Yang, Liangfan Xu, Yixiao Li, Jun Gao, Huajin He
  • Patent number: 11485656
    Abstract: Disclosed is a method for treating wastewater containing heavy metal. First, the wastewater containing heavy metal is subjected to a homogenization treatment, such that the water quality of the wastewater containing heavy metal from different processes is homogenized. The homogenized wastewater containing heavy metal is subjected to an anaerobic-aerobic circulating treatment in a membrane bioreactor (2), in which heavy metal ions are reduced by the action of microorganisms in the anaerobic treatment process. The membrane bioreactor (2) is filled with a hollow fiber membrane (3) containing a quinone group, which serves as an electron mediator that can accelerate the enzymatic reduction of heavy metal ions during the anaerobic treatment. During the aerobic treatment, the COD and SS in the wastewater are further removed.
    Type: Grant
    Filed: May 27, 2019
    Date of Patent: November 1, 2022
    Assignee: XIAMEN UNIVERSITY OF TECHNOLOGY
    Inventor: Bin Yan
  • Patent number: 11476501
    Abstract: The invention discloses a lithium metal anode protection method improving lithium utilization efficiency, and relates to the field of lithium batteries. In a lithium battery, lithium metal is deposited on a current collector as a battery anode, and a high molecular polymer is added as an additive to an ester electrolyte. In the present application, the high molecular polymer is prepared by a polymerization reaction of monomer A being acrylonitrile or derivatives thereof, monomer B being perfluoroalkyl ethyl methacrylate or derivatives thereof, and monomer C being alkyl alcohol diacrylate or derivatives thereof. Due to the negative charge on the surface of lithium metal, the —CN and —CF3 in the polymer are strong electron-withdrawing groups, which promote the preferential adsorption of electrolyte additives on the surface of lithium metal and reduce the contact of other components in the electrolyte with lithium metal.
    Type: Grant
    Filed: November 26, 2020
    Date of Patent: October 18, 2022
    Assignee: XIAMEN UNIVERSITY
    Inventors: Ling Huang, Qiong Wang, Ying Lei, Chenguang Shi, Shigang Sun
  • Patent number: 11464846
    Abstract: The invention relates to a mutated HPV66 L1 protein (or a variant thereof), a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein (or a variant thereof) and the virus-like particle can induce the generation of neutralizing antibodies against at least two HPV types (e.g. HPV66 and HPV56, or HPV66, HPV56 and HPV53), and therefore can be used to prevent infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum. The invention further relates to the use of the protein and the virus-like particle in the manufacture of a pharmaceutical composition or a vaccine for preventing infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum.
    Type: Grant
    Filed: June 4, 2019
    Date of Patent: October 11, 2022
    Assignees: XIAMEN UNIVERSITY, XIAMEN INNOVAX BIOTECH, CO., LTD.
    Inventors: Shaowei Li, Xinlin Liu, Yurou Yang, Jie Chen, Daning Wang, Ningshao Xia
  • Patent number: 11426459
    Abstract: The disclosure relates to a mutant of hemagglutinin protein of H3N2 subtype influenza virus and use thereof. In addition, the disclosure also relates to a pharmaceutical composition (e.g., a vaccine) comprising the mutant, a method for preparing the mutant, and a method of using the mutant for prevention and/or treatment of an infection of influenza virus and/or a disease (e.g., an influenza) caused by the infection.
    Type: Grant
    Filed: October 10, 2018
    Date of Patent: August 30, 2022
    Assignee: Xiamen University
    Inventors: Yixin Chen, Chenguang Shen, Junyu Chen, Mengya Zhang, Limin Zhang, Ningshao Xia
  • Patent number: 11413584
    Abstract: The present disclosure discloses a functional fluid gating control system, which comprises a porous membrane and a functional fluid. The functional fluid at least partially infiltrates the porous membrane and cooperates to form a fluid gating pathway. The functional fluid and/or the porous membrane responds to at least one stimulus and undergoes a physical change or a chemical change to change the threshold pressure of the transport substance. A transport fluid being immiscible with the functional fluid is controlled to pass through the fluid gating system, and thus controllable transport and multiphase separation of materials are achieved. The stimulus of the present disclosure comprises a wide range of sources, and the stimulus responsiveness of the functional fluid and the porous membrane can be randomly and freely combined to adapt to multiple stimuli from complex external conditions and achieve intelligent controllability.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: August 16, 2022
    Assignee: Xiamen University
    Inventors: Xu Hou, Zhizhi Sheng, Lizhi Huang, Lingli Min, Miao Wang, Yinglin Zhu, Feng Wu